Untargeted biochemical profiling to identify biomarkers of insulin resistance following the development of targeted assays and validation of the targeted assays in a clinical cohort resulted in the development of a diagnostic that monitors insulin sensitivity status in humans [52], [79]. The gene discussed is INS; the disease is Insulin resistance.